Coordination Chemistry Reviews, volume 232, issue 1-2, pages 95-126

Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized

Jane E. Weder 1
Carolyn T. Dillon 1
T. W. Hambley 1
Peter A. Lay 1
J.Ray Biffin 2
Hubert L. Regtop 2
Neal M Davies 3
Publication typeJournal Article
Publication date2002-10-10
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor20.6
ISSN00108545
Materials Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Abstract
The proposed curative properties of Cu-based non-steroidal anti-inflammatory drugs (NSAIDs) have led to the development of numerous Cu(II) complexes of NSAIDs with enhanced anti-inflammatory activity and reduced gastrointestinal (GI) toxicity compared with their uncomplexed parent drug. These low toxicity Cu drugs have yet to reach an extended human market, but are of enormous interest, because many of today's anti-inflammatory drug therapies, including those based on the NSAIDs, remain either largely inadequate and/or are associated with problematic renal, GI and cardiovascular side effects. The origins of the anti-inflammatory and gastric-sparing actions of Cu-NSAIDs, however, remain uncertain. Their ability to influence copper metabolism has been a matter of debate and, apart from their frequently reported superoxide dismutase (SOD)-like activity in vitro, relatively little is known about how they ultimately regulate the inflammatory process and/or immune system. Furthermore, little is known of their pharmacokinetic and biodistribution profile in both humans and animals, stability in biological media and pharmaceutical formulations, or the relative potency/efficacy of the Cu(II) monomeric versus Cu(II) dimeric complexes. The following review will not only discuss the etiology of inflammation, factors influencing the metabolism of copper and historical overview of the development of the Cu-NSAIDs, but also outline the structural characteristics, medicinal and veterinary properties, and proposed modes of action of the Cu-NSAIDs. It will also compare the SOD, anti-inflammatory and ulcerogenic effects of various Cu-NSAIDs. If the potential opportunities of the Cu-NSAIDs are to be completely realized, a mechanistic understanding and delineation of their in vivo and in vitro pharmacological activity is fundamental, along with further characterization of their pharmacokinetic/pharmacodynamic disposition.

Top-30

Citations by journals

10
20
30
40
50
60
Journal of Inorganic Biochemistry
56 publications, 12.47%
Polyhedron
43 publications, 9.58%
Journal of Molecular Structure
28 publications, 6.24%
Dalton Transactions
21 publications, 4.68%
Journal of Coordination Chemistry
21 publications, 4.68%
Inorganica Chimica Acta
17 publications, 3.79%
Applied Organometallic Chemistry
13 publications, 2.9%
New Journal of Chemistry
12 publications, 2.67%
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
9 publications, 2%
Inorganic Chemistry Communication
8 publications, 1.78%
Inorganic Chemistry
8 publications, 1.78%
Molecules
5 publications, 1.11%
Coordination Chemistry Reviews
5 publications, 1.11%
European Journal of Medicinal Chemistry
5 publications, 1.11%
RSC Advances
5 publications, 1.11%
Journal of Thermal Analysis and Calorimetry
4 publications, 0.89%
Chemical Papers
4 publications, 0.89%
Materials Science and Engineering C
4 publications, 0.89%
Acta Crystallographica Section E Structure Reports Online
3 publications, 0.67%
Inorganics
3 publications, 0.67%
International Journal of Molecular Sciences
3 publications, 0.67%
Journal of Biological Inorganic Chemistry
3 publications, 0.67%
Theoretical Chemistry Accounts
3 publications, 0.67%
Chemical Physics Letters
3 publications, 0.67%
European Journal of Inorganic Chemistry
3 publications, 0.67%
Chemistry - A European Journal
3 publications, 0.67%
Journal of Medicinal Chemistry
3 publications, 0.67%
Russian Chemical Bulletin
2 publications, 0.45%
Transition Metal Chemistry
2 publications, 0.45%
10
20
30
40
50
60

Citations by publishers

50
100
150
200
250
Elsevier
208 publications, 46.33%
Royal Society of Chemistry (RSC)
46 publications, 10.24%
Springer Nature
41 publications, 9.13%
Wiley
40 publications, 8.91%
Taylor & Francis
29 publications, 6.46%
American Chemical Society (ACS)
18 publications, 4.01%
Multidisciplinary Digital Publishing Institute (MDPI)
16 publications, 3.56%
Pleiades Publishing
6 publications, 1.34%
Walter de Gruyter
6 publications, 1.34%
Hindawi Limited
6 publications, 1.34%
International Union of Crystallography (IUCr)
5 publications, 1.11%
Beilstein-Institut
1 publication, 0.22%
CSIRO Publishing
1 publication, 0.22%
Mary Ann Liebert
1 publication, 0.22%
Future Medicine
1 publication, 0.22%
SAGE
1 publication, 0.22%
Frontiers Media S.A.
1 publication, 0.22%
IOP Publishing
1 publication, 0.22%
Korean Chemical Society
1 publication, 0.22%
King Saud University
1 publication, 0.22%
Scientific Publishers
1 publication, 0.22%
Scientific Research Publishing
1 publication, 0.22%
American Association for the Advancement of Science (AAAS)
1 publication, 0.22%
Society of Pharmaceutical Tecnocrats
1 publication, 0.22%
American Society for Microbiology
1 publication, 0.22%
Asian Journal of Chemistry
1 publication, 0.22%
American Institute of Physics (AIP)
1 publication, 0.22%
World Scientific
1 publication, 0.22%
RTU MIREA
1 publication, 0.22%
50
100
150
200
250
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Weder J. E. et al. Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized // Coordination Chemistry Reviews. 2002. Vol. 232. No. 1-2. pp. 95-126.
GOST all authors (up to 50) Copy
Weder J. E., Dillon C. T., Hambley T. W., Kennedy B., Lay P. A., Biffin J., Regtop H. L., Davies N. M. Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized // Coordination Chemistry Reviews. 2002. Vol. 232. No. 1-2. pp. 95-126.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S0010-8545(02)00086-3
UR - https://doi.org/10.1016/S0010-8545(02)00086-3
TI - Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
T2 - Coordination Chemistry Reviews
AU - Weder, Jane E.
AU - Dillon, Carolyn T.
AU - Hambley, T. W.
AU - Kennedy, Brendan
AU - Lay, Peter A.
AU - Biffin, J.Ray
AU - Regtop, Hubert L.
AU - Davies, Neal M
PY - 2002
DA - 2002/10/10 00:00:00
PB - Elsevier
SP - 95-126
IS - 1-2
VL - 232
SN - 0010-8545
ER -
BibTex |
Cite this
BibTex Copy
@article{2002_Weder,
author = {Jane E. Weder and Carolyn T. Dillon and T. W. Hambley and Brendan Kennedy and Peter A. Lay and J.Ray Biffin and Hubert L. Regtop and Neal M Davies},
title = {Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized},
journal = {Coordination Chemistry Reviews},
year = {2002},
volume = {232},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/S0010-8545(02)00086-3},
number = {1-2},
pages = {95--126},
doi = {10.1016/S0010-8545(02)00086-3}
}
MLA
Cite this
MLA Copy
Weder, Jane E., et al. “Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized.” Coordination Chemistry Reviews, vol. 232, no. 1-2, Oct. 2002, pp. 95-126. https://doi.org/10.1016/S0010-8545(02)00086-3.
Found error?